Former CEO Of Medtronic Brings More Than Three Decades of Product Development, Distribution and Leadership Experience
KING OF PRUSSIA, Pa., April 4, 2016/PRNewswire/ — Trice Medical, an early stage medical device company, announced the appointment of William Hawkins to the company’s board of directors, effective April 1, 2016. Hawkins joins a distinguished Board of proven industry leaders in their pursuit to revolutionize arthroscopic diagnostics. Mr. Hawkins is a renowned healthcare executive with diverse experience in healthcare delivery, innovation, and entrepreneurship.
“I am thrilled to have Bill as a Director. His experience in orthopedics and neurology combined with his extensive network will be very valuable as we build our distribution network and expand our product offering. Bill is a global, strategic thinker and will help us maximize the value of Trice,” said Jeffrey O’Donnell, Sr., President and CEO, Trice Medical.
Mr. Hawkins’ most recent position was with Immucor, Inc., where he served as its President and CEO from October 2011 to July 2015; currently, he is its Lead Director. Prior to joining Immucor, Mr. Hawkins served as Chairman and CEO of Medtronic, one of the world’s largest and most innovative medical technology companies. Mr. Hawkins’ career spans more than three decades. Before joining Medtronic, Mr. Hawkins was the CEO of Novoste, an Atlanta-based medical technology company. Mr. Hawkins has a consistent track record of driving value-creating innovation that has revolutionized medical care and strengthened healthcare systems globally. He has played a leadership role in Washington, DCon both healthcare policy and with matters involving the FDA.
“I am very excited to be joining Trice Medical’s board of directors as Jeffrey O’Donnell and his team continue to demonstrate the power of innovation – advancing the diagnostic tools for direct visualization of structural defects and improving the process of how patients are managed,” said Hawkins.
